Optimising risk stratification in primary biliary cirrhosis: AST/platelet ratio index predicts outcome independent of ursodeoxycholic acid response

Journal of Hepatology

Volumn 60, Issue 6, 2014, Pages 1249-1258

  Trivedi, Palak J ^a,b   Bruns, Tony ^a,c   Cheung, Angela ^d   Li, Ka Kit ^a,b   Kittler, Clemens ^c   Kumagi, Teru ^d,e   Shah, Husnain ^a,b   Corbett, Christopher ^a,b   Al Harthy, Nadya ^d,f   Acarsu, Unsal ^d   Coltescu, Catalina ^d   Tripathi, Dhiraj ^b   Stallmach, Andreas ^c   Neuberger, James ^b,g   Janssen, Harry L A ^d,h   Hirschfield, Gideon M ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c JENA UNIVERSITY HOSPITAL   (Germany)

^d TORONTO WESTERN HOSPITAL   (Canada)

^e EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f ROYAL HOSPITAL   (Oman)

^g NHS BLOOD AND TRANSPLANT   (United Kingdom)

^h ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Autoimmune liver disease; Cholestasis; Liver transplantation; Outcome prediction; Survival; Ursodeoxycholic acid

Indexed keywords

ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; URSODEOXYCHOLIC ACID; CHOLAGOGUE;

ADULT; ADVERSE OUTCOME; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE PLATELET RATIO INDEX; BILIRUBIN BLOOD LEVEL; FEMALE; FOLLOW UP; HEMATOLOGICAL PARAMETERS; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER TRANSPLANTATION; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PORTAL HYPERTENSION; PORTAL VEIN BLOOD FLOW; PREDICTIVE VALUE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL; THROMBOCYTE COUNT; TREATMENT RESPONSE; VALIDATION STUDY; AGE; AGED; BLOOD LEVEL; HUMAN TISSUE; LIVER GRAFT; MULTIVARIATE ANALYSIS; PREDICTOR VARIABLE; STATISTICAL SIGNIFICANCE; STRATIFICATION; THROMBOCYTE; VARICOSIS; BLOOD; DISEASE FREE SURVIVAL; FACTUAL DATABASE; KAPLAN MEIER METHOD; LIVER CIRRHOSIS, BILIARY; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

ADULT; ASPARTATE AMINOTRANSFERASES; CHOLAGOGUES AND CHOLERETICS; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; URSODEOXYCHOLIC ACID;

EID: 84901201265     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.01.029     Document Type: Article

References (21)

1. G.M. Hirschfield, and M.E. Gershwin The immunobiology and pathophysiology of primary biliary cirrhosis Annu Rev Pathol 8 2013 303 330
2. K.D. Lindor, M.E. Gershwin, R. Poupon, M. Kaplan, N.V. Bergasa, and E.J. Heathcote Primary biliary cirrhosis Hepatology 50 2009 291 308
3. P.-M. Huet, C. Vincent, J. Deslaurier, J. Coté, S. Matsutami, and R. Boileau et al. Portal hypertension and primary biliary cirrhosis: effect of long-term ursodeoxycholic acid treatment Gastroenterology 135 2008 1552 1560
4. C. Corpechot, L. Abenavoli, N. Rabahi, Y. Chrétien, T. Andréani, and C. Johanet et al. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis Hepatology 48 2008 871 877
5. T. Kumagi, M. Guindi, S.E. Fischer, T. Arenovich, R. Abdalian, and C. Coltescu et al. Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis Am J Gastroenterol 105 2010 2186 2194
6. A. Parés, L. Caballería, and J. Rodés Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid Gastroenterology 130 2006 715 720
7. C. Corpechot, O. Chazouillères, and R. Poupon Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome J Hepatol 55 2011 1361 1367
8. E.M.M. Kuiper, B.E. Hansen, R.A. de Vries, J.W. den Ouden-Muller, T.J.M. van Ditzhuijsen, and E.B. Haagsma et al. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid Gastroenterology 136 2009 1281 1287
9. M.G. Silveira, E.M. Brunt, J. Heathcote, G.J. Gores, K.D. Lindor, and M.J. Mayo American Association for the Study of Liver Diseases endpoints conference: design and endpoints for clinical trials in primary biliary cirrhosis Hepatology 52 2010 349 359
10. EASL Clinical Practice Guidelines Management of cholestatic liver diseases J Hepatol 51 2009 237 267
11. C.-T. Wai, J.K. Greenson, R.J. Fontana, J.D. Kalbfleisch, J.A. Marrero, and H.S. Conjeevaram et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C Hepatology 38 2003 518 526
12. F.E. Harrell Regression modeling strategies: with applications to linear models, log istic regression, and survival analysis 2001 Springer New York
13. D.G. Altman, and P. Royston The cost of dichotomising continuous variables BMJ 332 2006 1080
14. Z.-H. Lin, Y.-N. Xin, Q.-J. Dong, Q. Wang, X.-J. Jiang, and S.-H. Zhan et al. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis Hepatology 53 2011 726 736
15. E.R. Dickson, P.M. Grambsch, T.R. Fleming, L.D. Fisher, and A. Langworthy Prognosis in primary biliary cirrhosis: model for decision making Hepatology 10 1989 1 7
16. L.-N. Zhang, T.-Y. Shi, X.-H. Shi, L. Wang, Y.-J. Yang, and B. Liu et al. Early biochemical response to ursodeoxycholic acid and long-term prognosis of primary biliary cirrhosis: results of a 14-year cohort study Hepatology 58 1 2013 264 272
17. M. Carbone, G.F. Mells, G. Pells, M.F. Dawwas, J.L. Newton, and M.A. Heneghan et al. Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid Gastroenterology 144 2013 e7
18. C. Corpechot, F. Carrat, A. Bahr, Y. Chrétien, R.-E. Poupon, and R. Poupon The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis Gastroenterology 128 2005 297 303
19. C. Corpechot, F. Carrat, A. Poujol-Robert, F. Gaouar, D. Wendum, and O. Chazouillères et al. Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis Hepatology 56 2012 198 208
20. I. Patanwala, P. McMeekin, R. Walters, G. Mells, G. Alexander, and J. Newton et al. A validated clinical tool for the prediction of varices in PBC: the newcastle varices in PBC score J Hepatol 59 2013 327 335
21. P. Angulo, E. Bugianesi, E.S. Bjornsson, P. Charatcharoenwitthaya, P.R. Mills, and F. Barrera et al. Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease Gastroenterology 145 2013 e4